|
Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1028
|
$952B |
15.1x |
33.7x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$212
|
$537B |
5.7x |
15.1x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$223
|
$458B |
7.5x |
17.8x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$100
|
$272B |
4.2x |
9.3x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$318
|
$216B |
6.0x |
12.2x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$193B |
3.1x |
7.8x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$120
|
$167B |
5.7x |
10.6x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$52
|
$141B |
2.9x |
7.8x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$452
|
$110B |
9.2x |
21.2x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$119
|
$57.5B |
6.1x |
14.0x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$174
|
$28.2B |
2.9x |
9.2x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$12
|
$27.0B |
1.9x |
6.5x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$38
|
$23.5B |
7.9x |
8.2x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$153
|
$14.5B |
5.1x |
22.0x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$10.0B |
1.6x |
5.2x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$62
|
$8.1B |
6.1x |
9.4x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$269
|
$6.5B |
9756.6x |
-22.0x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$12
|
$6.3B |
2.1x |
9.3x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$42
|
$6.2B |
N/A |
-23.4x |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$141
|
$5.0B |
N/A |
N/A |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$105
|
$4.7B |
N/A |
-29.0x |
|
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$20
|
$4.7B |
9.3x |
20.4x |
|
Terns Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$45
|
$4.6B |
N/A |
-41.1x |
|
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$47
|
$4.5B |
N/A |
-11.5x |
|
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$28
|
$3.7B |
2.5x |
9.6x |
|
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$3.5B |
126.1x |
N/A |
|
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$29
|
$3.5B |
9.9x |
-467.7x |
|
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$35
|
$3.2B |
6.6x |
4634.1x |
|
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$81
|
$3.1B |
7.2x |
-47.5x |
|
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$3.0B |
5.2x |
23.6x |
|
WAVE Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$2.9B |
64.5x |
-14.7x |
|
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$92
|
$2.9B |
N/A |
-12.4x |
|
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$30
|
$2.8B |
36.6x |
-22.2x |
|
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$42
|
$2.8B |
4.2x |
28.0x |
|
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$2.5B |
3.5x |
19.0x |
|
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$34
|
$2.5B |
N/A |
-11.5x |
|
Nuvation Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$2.4B |
45.1x |
N/A |
|
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$2.3B |
N/A |
-13.8x |
|
Olema Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$33
|
$2.3B |
N/A |
-13.8x |
|
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$80
|
$2.2B |
2.5x |
9.7x |
|
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$49
|
$2.1B |
2.7x |
4.5x |
|
Avadel Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$2.0B |
7.4x |
62.8x |
|
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$22
|
$1.9B |
7.9x |
-5.4x |
|
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$1.9B |
7.1x |
27.6x |
|
Zenas BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$41
|
$1.9B |
56.1x |
-9.4x |
|
Aurinia Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$1.8B |
6.5x |
N/A |
|
Zymeworks
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$25
|
$1.7B |
13.8x |
-30.2x |
|
Sionna Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$43
|
$1.7B |
N/A |
-18.9x |
|
Stoke Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$32
|
$1.6B |
8.8x |
242.2x |
|
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$25
|
$1.5B |
2.1x |
5.9x |
|
Maze Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Digital Therapeutics
|
$39
|
$1.5B |
205.7x |
-11.5x |
|
Ardelyx
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$1.5B |
3.7x |
-334.1x |
|
Dianthus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$42
|
$1.4B |
572.7x |
N/A |
|
Xeris Biopharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$1.4B |
4.8x |
26.8x |
|
Syndax
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$1.3B |
8.2x |
-4.9x |
|
Savara
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$1.3B |
N/A |
N/A |
|
Sana Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$1.3B |
N/A |
-6.3x |
|
Innoviva
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$21
|
$1.3B |
3.2x |
N/A |
|
Pharvaris
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$24
|
$1.2B |
N/A |
-6.3x |
|
Tango Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$1.1B |
18.4x |
N/A |
|
Esperion Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$4
|
$1.1B |
2.9x |
40.8x |
|
Phathom Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$1.1B |
6.6x |
-7.6x |
|
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$1.1B |
418.3x |
-7.3x |
|
Mind Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$1.1B |
N/A |
-6.7x |
|
Ironwood Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$4
|
$1.0B |
3.5x |
7.0x |
|
OPKO Health
|
United States of America |
Biopharmaceuticals,
Medical Imaging & Diagnostics
|
$1
|
$1.0B |
1.7x |
-7.5x |
|
UroGen Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$22
|
$1.0B |
9.1x |
-8.8x |
|
Oculis Holding
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$21
|
$1.0B |
1041.8x |
-10.3x |
|
Emergent BioSolutions
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$1.0B |
1.2x |
5.1x |
|
MBX Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$30
|
$950M |
N/A |
-9.3x |
|
Rapport Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$30
|
$942M |
N/A |
-8.1x |
|
Tyra Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$939M |
N/A |
-7.2x |
|
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$905M |
2.7x |
35.2x |
|
Alumis
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$860M |
36.2x |
-3.5x |
|
Relay Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$829M |
65.5x |
-2.6x |
|
Arbutus Biopharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$813M |
59.6x |
N/A |
|
Erasca
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$781M |
N/A |
-5.4x |
|
Xencor
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$778M |
6.1x |
-4.8x |
|
Bicara Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$18
|
$724M |
N/A |
-4.9x |
|
ArriVent BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$24
|
$708M |
N/A |
-4.7x |
|
Septerna
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Small Molecules
|
$25
|
$689M |
19.7x |
-10.9x |
|
ORIC Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$630M |
N/A |
-4.4x |
|
Astria Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$610M |
90.1x |
-3.9x |
|
Annexon
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$579M |
N/A |
-2.6x |
|
Enliven Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$523M |
65689.7x |
-4.6x |
|
Elite Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$517M |
N/A |
N/A |
|
Regenxbio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$504M |
2.6x |
-4.6x |
|
CytoDyn
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$0
|
$426M |
N/A |
N/A |
|
Lexicon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$415M |
8.9x |
-6.2x |
|
Day One Biopharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$410M |
2.8x |
-3.3x |
|
Armata Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$378M |
71.3x |
-12.0x |
|
Cullinan Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$373M |
63.7x |
-1.7x |
|
LENZ Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$18
|
$366M |
20.1x |
-4.7x |
|
Altimmune
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$5
|
$355M |
34010.5x |
-3.9x |
|
4D Molecular Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$337M |
10.5x |
-1.7x |
|
Akebia Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$2
|
$327M |
1.4x |
N/A |
|
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$0
|
$322M |
N/A |
N/A |
|
Mereo BioPharma Group
|
United States of America |
Biopharmaceuticals
|
$2
|
$297M |
21.4x |
-6.8x |
|
SIGA Technologies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$6
|
$291M |
2.9x |
9.4x |
|
Nika Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$0
|
$291M |
N/A |
N/A |